Portfolio comparison
University of Pennsylvania vs Transkaryotic Therapies Inc
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
University of Pennsylvania
Patents indexed
2
Year range
2022
Most recent
2022
biotechpharmaceuticalgene_editing
Top Patents2 enriched
US 11499167· 2022
Engineering Cells to Make Gene Therapy Viruses Using AAVrh.10
US 11357868· 2022
New Adeno-Associated Virus Capsids for Gene Therapy
Activity by Decade
2020s2
Company B
Transkaryotic Therapies Inc
Patents indexed
1
Year range
2003
Most recent
2003
biotechpharmaceutical
Top Patents1 enriched
US 6531124· 2003
How to Use Modified Cells to Produce Insulin-Regulating Proteins in the Body
Activity by Decade
2000s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.